OB/GYN

Latest News



What goes wrong with blood cells and genes of children who suffer this grim disease? And how has a high cure rate revealed late effects of treatment? Answers to these (and more) questions shape your ongoing basic care of patients at the onset of, during, and after their illness.

Expanding knowledge, new screening technologies, and effective vaccines have opened new horizons in, and put pediatricians at the forefront of, preventing cervical cancer and other diseases caused by human papillomavirus. Here's what we know now and what it means for your patients. First of two parts.

Two separate studies show that Merck & Co.'s and GlaxoSmithKline's human papillomavirus (HPV) vaccines appear highly effective in preventing cervical cancer, vulvar cancer, and genital warts.The recently completed trials involved Merck's Gardasil and GlaxoSmithKline's experimental vaccine. Earlier studies showed that Gardasil also protects against cervical intraepithelial neoplasia (CIN)-precancerous lesions that can develop into cervical cancer.

Eye on Washington

Health spending for 2006 uncertain, cesarean rate is up nationally, Hepatitis A vaccination now for all children.

There will be many new vaccines and new vaccine recommendations over the next three years or so, two of the top experts in the vaccine arena reported today at the AAP National Conference.

There will be many new vaccines and new vaccine recommendations over the next three years or so, two of the top experts in the vaccine arena reported today at the AAP National Conference.

Prompt diagnosis and treatment of what was once considered a rare disorder of early childhood can eliminate symptoms and prevent long-term problems, such as osteoporosis and intestinal cancer.

Contrary to earlier findings, inhaled nitric oxide (NO) therapy for lung immaturity in premature infants does not reduce an infant's risk of death or further lung problems, according to a study by the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health that appeared in the July 7 issue of the New England Journal of Medicine. "Premature infants weighing less than 1,500 g should not receive inhaled NO therapy unless they are part of a research study," said NICHD Director Duane Alexander, MD.

Your latest case: A 3-month-old girl with a pink, macular, anterior inguinal rash with satellite lesions that suggests diaper candidiasis, and a firm, nontender, 1 x 1-cm mass in the right inguinal area that is freely mobile.